News around the biocity campus

Major progress on global biodiversity observation system

iDiv Leipzig. iDiv hosted a three day workshop where scientists and technical and legal experts made great steps towards the development of a cooperative and global monitoring system for changes in biodiversity. The workshop, which was a breakthrough in global collaboration, was organized for the first time as part of the EU horizon 2020 project GLOBIS-B, coordinated by the University of Amsterdam.

The fast growing global human population and climate change drive environmental modifications which might lead to poverty, social unrest and wars. But which dimensions of the environment are changing most dramatically, where are these changes happening and what will be the consequences for biodiversity? During the workshop at iDiv (29 Feb – 2 Mar), biodiversity scientists, technical experts from research infrastructures and advisors for legal interoperability of data defined so called Essential Biodiversity Variables (EBVs) to address these questions.

Read more in the press release of the University of Amsterdam at http://ibed.uva.nl/news-events/news/content4/2016/03/major-progress-on-global-biodiversity-observation-system.html & http://geobon.org/workshop-1-globis-b/


Previous News

More is better: the diversity and number of soil animals determine leaf decomposition in the forest

iDiv Leipzig/Göttingen. Small animals that decompose fallen leaves in the forest form complex food webs and are essential to a functioning ecosystem. A study comprising over 80 forests in Germany and on Sumatra (Indonesia) has now shown that two factors particularly influence this function when examined over larger landscapes: the number of animals and their species diversity. In previous studies, the connection between biodiversity and ecosystem functioning had been investigated mostly in small test areas. […]

Next News

RIBOLUTION Health GmbH founded in Leipzig

Fraunhofer IZI. The new biotech start-up in Leipzig, Germany, aims to improve diagnosis and therapy of complex diseases such as cancer, chronic inflammatory and infectious diseases. First planned products are tests for diagnosis and prognosis of prostate cancer that offer higher accuracy compared to conventional processes. […]